NICOLE MOORE: Open Payments
NPI 1700149101 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,568 in 148 payments from 17 companies in 2025. Trend: 2023 $1,558 · 2024 $1,701 · 2025 $2,568
Food & beverage: $2,568
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $666 |
| Janssen Biotech, Inc. | 21 | $364 |
| Phathom Pharmaceuticals, Inc. | 18 | $271 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $252 |
| GENZYME CORPORATION | 7 | $184 |
| Ardelyx, Inc. | 10 | $150 |
| QOL Medical, LLC | 5 | $137 |
| PFIZER INC. | 6 | $98 |
| Regeneron Healthcare Solutions, Inc. | 5 | $97 |
| Gilead Sciences, Inc. | 3 | $71 |
Products named: TREMFYA, RINVOQ, DUPIXENT, VOQUEZNA, ENTYVIO, IBSRELA, Sucraid, CREON.
Industry payments across IN — which companies pay providers there.
